Companies Mentioned

Ortho McNeil Pharmaceutical, Inc.

Category
Title
Summary
Date
Commentaries
Patent Law

Agrizap and Ortho-McNeil: Two Sides of Post-KSR Obviousness
In KSR v. Teleflex, 550 U.S. ____, 127 S. Ct. 1727 (2007), the U.S. Supreme Court broadened the applicable test in determining whether an invention is “obvious.” As predicted by patent law pundits, the KSR decision was followed by a number of cases in which infringers defended their actions –…
Posted:
05/16/2008
Summaries
Patent Law >
New Judicial Opinions

Federal Circuit Affirms Validity of Ortho-McNeil’s Patent On Epilepsy Drug Topomax
Patent (‘006 patent) at issue relates to Topiramate, a drug that is distributed by plaintiff Ortho-McNeil Pharmaceutical, Inc. (“plaintiff”) as Topomax.  It is a significant epilepsy drug that was formulated during a search for new anti-diabetic drugs. On the other hand, defendant Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. (“defendant”)…
Date of ruling:
03/31/2008